CLINICAL_TRIALS
trial_result
· 2015-11-26
Clinical Trial Update: Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis [Phase 2]
Summary
A Phase 2 safety, tolerability and efficacy study of LiRIS 400 mg in women with interstitial cystitis was terminated, and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Interstitial Cystitis | Phase 2 | Status: TERMINATED | Results posted: 2015-11-26